Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Omnicell (OMCL) USD (CDI)

Sell:$80.91 Buy:$80.93 Change: $0.74 (0.91%)
NASDAQ:0.73%
Market closed |  Prices as at close on 12 December 2019 | Switch to live prices |
Sell:$80.91
Buy:$80.93
Change: $0.74 (0.91%)
Market closed |  Prices as at close on 12 December 2019 | Switch to live prices |
Sell:$80.91
Buy:$80.93
Change: $0.74 (0.91%)
Market closed |  Prices as at close on 12 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Contact details

Address:
590 E Middlefield Rd
MOUNTAIN VIEW
94043-4008
United States
Telephone:
+1 (650) 2516100
Website:
https://www.omnicell.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
OMCL
ISIN:
US68213N1090
Market cap:
$3.44 billion
Shares in issue:
41.94 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Randall Lipps
    Chairman of the Board, President, Chief Executive Officer
  • Peter Kuipers
    Chief Financial Officer, Executive Vice President
  • Daniel Johnston
    Executive Vice President, Chief Legal and Administrative Officer
  • Nhat Ngo
    Executive Vice President - Marketing, Strategy and Business Development
  • Scott Seidelmann
    Executive Vice President and Chief Commercial Officer
  • Jorge Taborga
    Executive Vice President - Engineering and Integration Management Office
  • Joseph Spears
    Vice President, Corporate Finance and Chief Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.